Tandem Diabetes Care reported $-0.1 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -0.10 -0.20 -0.31 Nov/05
FY2026Q2 Jun/2026 -0.31 -0.33 -0.78 Aug/06
FY2026Q1 Mar/2026 -0.30 -0.44 -1.97 May/07
FY2025Q4 Dec/2025 -0.01 -0.09 0.01 Feb/19
FY2025Q3 Sep/2025 -0.31 -0.33 -0.35 Nov/06




Eps Change Date
Abbott USD 0.53 0.78 Sep/2026
Accuray USD 0.02 0.06 Dec/2024
Align Technology USD 2.8 0.16 Sep/2026
AtriCure USD 0.17 0.01 Sep/2026
Baxter International USD 0.58 0.02 Sep/2026
Becton, Dickinson and Co. USD 2.52 0.71 Sep/2026
Boston Scientific USD 0.73 0.13 Sep/2026
Cooper Companies USD 2.24 1.2 Jun/2026
Dexcom USD 0.73 0.03 Sep/2026
Edwards Lifesciences USD 0.8 0.02 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Globus Medical USD 1.23 0.11 Sep/2026
ICU Medical USD 2.44 0.07 Sep/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.99 0.33 Sep/2026
Integra LifeSciences USD 0.6 0.04 Sep/2026
Intuitive Surgical USD 2.78 0.02 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Medtronic USD 1.45 0.1 Jun/2026
Merit Medical Systems USD 1.12 0.07 Sep/2026
Orthofix International USD 0.08 0.12 Dec/2025
Roche Holding CHF 10.98 2.61 Jun/2026
Stryker USD 3.52 0.17 Sep/2026
Tandem Diabetes Care USD -0.1 0.21 Sep/2026
Teleflex USD 2.63 0.87 Sep/2026
Zimmer Biomet Holdings USD 1.9 0.17 Sep/2026